P74.41
Alkalosis of newborn
Clinical Classification Guidelines
Inclusion Terms
- Hyperbicarbonatemia
Medical Intelligence & Overview
Alkalosis of the newborn is a condition characterized by an elevated blood pH, leading to a state known as alkalemia. Specifically, this condition involves an excessive amount of bicarbonate in the blood, known as hyperbicarbonatemia, which disrupts the body's acid-base balance. It typically occurs in newborns due to various underlying factors affecting their metabolic or respiratory systems. Prompt recognition and management of this condition are essential for the well-being of affected infants.
Causes & Symptoms
Clinical Causes: Respiratory problems leading to decreased carbon dioxide levels Metabolic imbalances caused by dehydration or renal issues Exposure to certain medications or substances affecting acid-base regulation Infections or sepsis that disturb metabolic processes Complications during labor or delivery affecting oxygen and carbon dioxide exchange
Key Symptoms: Irritability or lethargy Muscle twitching or tremors Deep, rapid breathing (hyperventilation) Weakness or fatigue Potential seizures in severe cases Feeding difficulties or poor feeding
Diagnostic & Treatment
Diagnosis Path: Diagnosing alkalosis of the newborn involves a combination of clinical assessment and laboratory testing. Key steps include:
Treatment Protocols: Treatment strategies focus on correcting the underlying cause and restoring acid-base balance. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is P74.41 a billable ICD-10 code?
Yes, P74.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P74.41?
Clinical documentation must specify the nature of Alkalosis of newborn and any associated comorbidities for accurate reporting.
Cite this Clinical Reference